Test Code VHPV Human Papillomavirus (HPV) Vaginal Detection with Genotyping for High-Risk Types by PCR
Necessary Information
Specimen source is required.
Specimen Required
Specimen Type: Vaginal
Container/Tube: ThinPrep/PreservCyt solution vial
Specimen Volume: 3 mL of solution in ThinPrep/PreservCyt vial
Collection Instructions:
1. Bag ThinPrep specimens individually as they have a tendency to leak during transport.
2. Place labels on the vial and on the bag.
Useful For
Detection of high-risk (HR) genotypes associated with the development of cervical cancer
Aids in triaging women with abnormal Pap smear results
Individual genotyping of human papillomavirus (HPV)-16 and/or HPV-18 if present
Results of HPV-16 and HPV-18 genotyping can aid in triaging women with positive HR-HPV but negative Pap smear results
This testing is intended for use in clinical monitoring and management of patients. It is not intended for use in medical-legal applications.
This test is not intended for use in determining the need for treatment (ie, excisional or ablative treatment of the cervix) in the absence of high-grade cervical dysplasia. Patients who are HPV16/18 positive should be monitored carefully for the development of high-grade cervical dysplasia according to current practice guidelines.
This test is not intended for use with samples other than those collected by a clinician using an endocervical brush or spatula and placed in the ThinPrep Pap test PreservCyt solution.
Method Name
Real-Time Polymerase Chain Reaction (PCR)
Reporting Name
HPV Vaginal Detect / Genotyping PCRSpecimen Type
VaginalSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Vaginal | Ambient (preferred) | 42 days | |
Refrigerated | 42 days |
Reject Due To
Specimen containing CytoRich Red preservative fluid | Reject |
Reference Values
Negative for human papillomavirus (HPV) genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68
Interpretation
A positive result indicates the presence of human papillomavirus (HPV) DNA from one or more of the following genotypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.
For patients with atypical squamous cells of undetermined significance Pap smear result and who are positive for high-risk (HR) HPV, consider referral for colposcopy, if clinically indicated.
A negative result indicates the absence of HPV DNA of the targeted genotypes.
For women aged 30 years and older with a negative Pap smear test result but who are positive for HPV-16 and/or HPV-18, consider referral for colposcopy, if clinically indicated.
For women aged 30 years and older with a negative Pap smear test result, positive-HR-HPV test result, but who are negative for HPV-16 and HPV-18, consider repeat testing by both cytology and a HR-HPV test in 12 months.
Day(s) Performed
Monday through Saturday
Report Available
3 to 6 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
87624
G0476 (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
VHPV | HPV Vaginal Detect / Genotyping PCR | 77378-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
619403 | HPV High Risk type 16, PCR | 61372-9 |
619404 | HPV High Risk type 18, PCR | 61373-7 |
619405 | HPV other High Risk types, PCR | 77375-4 |
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.